Trials / Completed
CompletedNCT04529616
Single Center Exploratory Study To Evaluate The Use Of The RxSight Light Adjustable Lens (LAL) And The Light Delivery Device (LDD) To Improve Visual Outcomes
- Status
- Completed
- Phase
- —
- Study type
- Interventional
- Enrollment
- 79 (actual)
- Sponsor
- RxSight, Inc. · Industry
- Sex
- All
- Age
- 30 Years
- Healthy volunteers
- Not accepted
Summary
The objective of this study is to evaluate, for the visual correction of aphakia, whether the RxSight Light Adjustable Lens (LAL) and Light Delivery Device (LDD) can be used to improve visual outcomes after performing adjustments of the LAL with the LDD. This is an exploratory study. No primary effectiveness endpoints will be identified.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Light Adjustable lens (LAL) and Light Delivery Device (LDD) | Eligible eyes will receive Light adjustable lens with Light delivery Device treatments |
Timeline
- Start date
- 2020-05-22
- Primary completion
- 2022-10-01
- Completion
- 2022-10-01
- First posted
- 2020-08-27
- Last updated
- 2025-02-10
- Results posted
- 2025-02-10
Locations
1 site across 1 country: Mexico
Source: ClinicalTrials.gov record NCT04529616. Inclusion in this directory is not an endorsement.